OMALIZUMAB

Omalizumab 150 mg/mL injection, 1 mL pen device

OMALIZUMAB (14923K)

Omalizumab 150 mg/mL injection, 1 mL pen device
14923K
Body System:
Manner of administration:Injection
Private
S100 HSD Private
Authority Required

Restriction

Indication: Uncontrolled severe asthma
Treatment phase: Initial treatment - Initial 1 (New patients; or Recommencement of treatment in a new treatment cycle following a break in PBS subsidised biological medicine therapy)

Restriction

Indication: Uncontrolled severe asthma
Treatment phase: Initial treatment - Initial 2 (Change of treatment)
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 7 DPMQ: $223.46 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Omlyclo
Xolair